Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Patent
1993-09-20
1994-09-06
Bond, Robert T.
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
C07D49116, A61K 31395
Patent
active
053449258
ABSTRACT:
Imidazolidyl macrolides of the general structural Formula I: ##STR1## have been prepared from suitable precursors by alkylation and/or arylation at C-3" and/or C-4" of the cyclohexyl ring. These macrolide immunosuppressants are useful in a mammalian host for the treatment of autoimmune diseases, infectious diseases the prevention of rejection of foreign organ transplants and/or related afflictions, diseases and illnesses.
REFERENCES:
patent: 3244592 (1966-04-01), Arai
patent: 5162334 (1992-11-01), Goulet et al.
patent: 5189042 (1993-02-01), Goulet et al.
patent: 5190950 (1993-03-01), Beattie et al.
patent: 5208228 (1993-05-01), Ok et al.
patent: 5208241 (1993-05-01), Ok et al.
patent: 5247076 (1993-09-01), Goulet et al.
patent: 5250678 (1993-10-01), Goulet et al.
patent: 5252732 (1993-10-01), Sinclair et al.
patent: 5262533 (1993-11-01), Sinclair et al.
Thompson, et al., Springer Semin. Immunopathol., 14, 323-344 (1993).
Goulet Mark
Sinclair Peter J.
Wong Frederick
Wyvratt Matthew J.
Bond Robert T.
DiPrima Joseph F.
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
Imidazolidyl macrolides having immunosuppressive activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolidyl macrolides having immunosuppressive activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolidyl macrolides having immunosuppressive activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1330264